These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 26118637)

  • 1. Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
    Chu R; Tauhid S; Glanz BI; Healy BC; Kim G; Oommen VV; Khalid F; Neema M; Bakshi R
    J Neuroimaging; 2016; 26(1):62-7. PubMed ID: 26118637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-brain atrophy assessed by proportional- versus registration-based pipelines from 3T MRI in multiple sclerosis.
    Hemond CC; Chu R; Tummala S; Tauhid S; Healy BC; Bakshi R
    Brain Behav; 2018 Aug; 8(8):e01068. PubMed ID: 30019857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.
    Chu R; Kim G; Tauhid S; Khalid F; Healy BC; Bakshi R
    PLoS One; 2018; 13(11):e0206939. PubMed ID: 30408094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability.
    Chu R; Hurwitz S; Tauhid S; Bakshi R
    BMC Neurol; 2017 Sep; 17(1):172. PubMed ID: 28874119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI-based measurements of whole-brain global cerebral blood flow: Comparison and validation at 1.5T and 3T.
    Chen CM; Huang YC; Shih CT; Chen YF; Peng SL
    J Magn Reson Imaging; 2018 Nov; 48(5):1273-1280. PubMed ID: 29479823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study.
    Singhal T; O'Connor K; Dubey S; Pan H; Chu R; Hurwitz S; Cicero S; Tauhid S; Silbersweig D; Stern E; Kijewski M; DiCarli M; Weiner HL; Bakshi R
    Neurol Neuroimmunol Neuroinflamm; 2019 Sep; 6(5):e587. PubMed ID: 31355321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-Sensitivity Multiple Sclerosis Lesion and CSF Segmentation for Multichannel 3T Brain MRI.
    Meier DS; Guttmann CRG; Tummala S; Moscufo N; Cavallari M; Tauhid S; Bakshi R; Weiner HL
    J Neuroimaging; 2018 Jan; 28(1):36-47. PubMed ID: 29235194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis.
    Tauhid S; Chu R; Sasane R; Glanz BI; Neema M; Miller JR; Kim G; Signorovitch JE; Healy BC; Chitnis T; Weiner HL; Bakshi R
    J Neurol; 2015 Nov; 262(11):2425-32. PubMed ID: 26205635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central Atrophy Early in Multiple Sclerosis: Third Ventricle Volumetry versus Planimetry.
    Lutz T; Bellenberg B; Schneider R; Weiler F; Köster O; Lukas C
    J Neuroimaging; 2017 May; 27(3):348-354. PubMed ID: 27897360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study.
    Uher T; Krasensky J; Vaneckova M; Sobisek L; Seidl Z; Havrdova E; Bergsland N; Dwyer MG; Horakova D; Zivadinov R
    J Neuroimaging; 2017 Nov; 27(6):620-629. PubMed ID: 28464417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing 3T and 1.5T MRI for mapping hippocampal atrophy in the Alzheimer's Disease Neuroimaging Initiative.
    Chow N; Hwang KS; Hurtz S; Green AE; Somme JH; Thompson PM; Elashoff DA; Jack CR; Weiner M; Apostolova LG;
    AJNR Am J Neuroradiol; 2015 Apr; 36(4):653-60. PubMed ID: 25614473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI-Defined Corpus Callosal Atrophy in Multiple Sclerosis: A Comparison of Volumetric Measurements, Corpus Callosum Area and Index.
    Granberg T; Bergendal G; Shams S; Aspelin P; Kristoffersen-Wiberg M; Fredrikson S; Martola J
    J Neuroimaging; 2015; 25(6):996-1001. PubMed ID: 25786805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying brain volumes for Multiple Sclerosis patients follow-up in clinical practice - comparison of 1.5 and 3 Tesla magnetic resonance imaging.
    Lysandropoulos AP; Absil J; Metens T; Mavroudakis N; Guisset F; Van Vlierberghe E; Smeets D; David P; Maertens A; Van Hecke W
    Brain Behav; 2016 Feb; 6(2):e00422. PubMed ID: 27110445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Glatiramer Acetate on Spinal Cord Volume in Relapsing-Remitting Multiple Sclerosis.
    Singhal T; Tauhid S; Hurwitz S; Neema M; Bakshi R
    J Neuroimaging; 2017 Jan; 27(1):33-36. PubMed ID: 27466943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal cord atrophy in anterior-posterior direction reflects impairment in multiple sclerosis.
    Lundell H; Svolgaard O; Dogonowski AM; Romme Christensen J; Selleberg F; Soelberg Sørensen P; Blinkenberg M; Siebner HR; Garde E
    Acta Neurol Scand; 2017 Oct; 136(4):330-337. PubMed ID: 28070886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis.
    Khalid F; Tauhid S; Chua AS; Healy BC; Stankiewicz JM; Weiner HL; Bakshi R
    Int J Neurosci; 2017 May; 127(5):396-403. PubMed ID: 27143245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of global cerebral atrophy in multiple sclerosis from 3T MRI using SPM: the role of misclassification errors.
    Dell'Oglio E; Ceccarelli A; Glanz BI; Healy BC; Tauhid S; Arora A; Saravanan N; Bruha MJ; Vartanian AV; Dupuy SL; Benedict RHB; Bakshi R; Neema M
    J Neuroimaging; 2015; 25(2):191-199. PubMed ID: 25523616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine.
    Ghione E; Bergsland N; Dwyer MG; Hagemeier J; Jakimovski D; Paunkoski I; Ramasamy DP; Silva D; Carl E; Hojnacki D; Kolb C; Weinstock-Guttman B; Zivadinov R
    AJNR Am J Neuroradiol; 2018 Dec; 39(12):2237-2242. PubMed ID: 30467212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salient Central Lesion Volume: A Standardized Novel Fully Automated Proxy for Brain FLAIR Lesion Volume in Multiple Sclerosis.
    Dwyer MG; Bergsland N; Ramasamy DP; Weinstock-Guttman B; Barnett MH; Wang C; Tomic D; Silva D; Zivadinov R
    J Neuroimaging; 2019 Sep; 29(5):615-623. PubMed ID: 31259467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.